SSX5 Antikörper

Produktnummer ABIN2458407

Produktdetails anti-SSX5 Antikörper

Target: SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Aufreinigung: Antibody is purified by peptide affinity chromatography method.

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human SSX5.

Anwendungsinformationen

Applikationshinweise: SSX5 antibody can be used for detection of SSX5 by ELISA at 1:62500. SSX5 antibody can be used for detection of SSX5 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.

Konzentration: 1 mg/mL

Buffer: Antibody is lyophilized in PBS buffer with 2 % sucrose.

Handhabung: As with any antibody avoid repeat freeze-thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: For short periods of storage (days) store at 4 °C. For longer periods of storage, store SSX5 antibody at -20 °C.

Details zu SSX5

Target: SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))

Andere Bezeichnung: SSX5 (SSX5 Produkte)

Synonyme: putative protein SSX6 antikoerper, synovial sarcoma, X breakpoint 5 antikoerper, SSX family member 5 antikoerper, LOC612524 antikoerper, SSX5 antikoerper

Hintergrund: SSX5 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t (X,18) translocation characteristically found in all synovial sarcomas. The gene encoding SSX5 appears not to be involved in this type of chromosome translocation. The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t (X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation. Two transcript variants encoding distinct isoforms have been identified for this gene.

Molekulargewicht: 26 kDa

Gen-ID: 6758

NCBI Accession: NP_066295

UniProt: Q5JQ60